IN VITRO INDUCTION OF BLOOD MONONUCLEAR CELL PROLIFERATION BY ENDOGENOUS RETROVIRAL HERV-Eλ4-1 ENVELOPE PEPTIDE IN PATIENTS WITH MULTIPLE SCLEROSIS
https://doi.org/10.15789/1563-0625-2014-3-247-256
Abstract
A comparative in vitro study of blood mononuclear cells from multiple sclerosis patients and healthy donors was performed, in order to evaluate proliferative response to a retroviral antigen, aiming to determine immunomodulatory properties of synthetic oligopeptide homologous to a highly conserved human endogenous retrovirus HERV-Eλ4-1 envelope protein. It was revealed that this oligopeptide is able to stimulate the in vitro spontaneous and mitogen-induced proliferation of blood mononuclear cells from either donor and multiple sclerosis patients. Intensity of this oligopeptide-induced stimulatory effect depends on the protein concentration, and on initial level of blood immunocompetent cells proliferation. Hence, the endogenous retrovirus HERV-Eλ4-1 envelope region protein is able to increase functional activity of immunocompetent cells from human blood, that suggesting its immunostimulatory properties. It is possible that the mitogenic effects of this protein upon immunocompetent cells of multiple sclerosis patients represent a potential mechanism of retroviral involvement into pathogenesis of the disorder.
About the Authors
A. A. SmaginRussian Federation
I. A. Goldina
Russian Federation
K. V. Gaidul
Russian Federation
M. S. Lubarsky
Russian Federation
References
1. Goldina I.A., Gaydul K.V., Kozlov V.A. Endogennyy retrovirus cheloveka HERV-Eλ4-1 v patogeneze rasseyannogo skleroza: immunomoduliruyushchie svoystva retrovirusnogo peptida [Human endogenous retrovirus HERV-Eλ4-1 in multiple sclerosis pathogenesis]. Neyroimmunologiya – Neuroimmunology, 2011, vol. IX, no. 3-4, pp. 55-56.
2. Goldina I.A., Gaydul K.V., Markova E.V., Kozlov V.A. Kletochnyy immunnyy otvet pri vozdeystvii rekombinantnogo peptida, gomologichnogo aminokislotnoy posledovatel`nosti endogennogo retrovirusa cheloveka I klassa HERV-Eλ4-1 [Cellular immune response under the influence of recombinant peptide homologous to the aminoacid sequence of I class human endogenous retrovirus HERV-Eλ4-1]. Vestnik ural`skoy meditsinskoy akademicheskoy nauki – Bulletin of the Ural Academic Medical Science, 2009, vol. 2/1, no. 24, pp. 28-30.
3. Goldina I.A., Safronova I.V., Postnikov V.A, Sizikov A.E., Gaydul K.V. Ekspressiya gena envelope endogennogo retrovirusa cheloveka I klassa λ4-1 v mononuklearnykh kletkakh krovi bol`nykh revmatoidnym artritom i deformiruyushchim osteoartrozom [I class human endogenous retrovirus λ4-1 expression in blood mononuclear cells of deforming osteoarthritis and rheumatoid arthritis patients]. Vestnik ural`skoy meditsinskoy akademicheskoy nauki – Bulletin of the Ural Academic Medical Science, 2009, vol. 2/1, no.24, pp. 95-96.
4. Goldina I.A., Gaydul K.V., Smagin A.A., Safronova I.V., Goldin B.G., Pavlov V.V., Lubarsky M.S., Kozlov V.A. Ekspressiya gena envelope endogennogo retrovirusa cheloveka I klassa v mononuklearnykh kletkakh krovi bol`nykh rasseyannym sklerozom [I class human endogenous retrovirus envelope gene expression in blood mononuclear cells of multiple sclerosis patients]. Molekulyarnaya meditsina – Molecular Medicine, 2011, no. 1, pp. 31-35.
5. Koval`chuk L.V., Cheredeev A.N. Aktual`nye problemy otsenki immunnoy sistemy cheloveka na sovremennom etape [Actual problems of human immune system estimation at current stage]. Immunologiya – Immunology, 1990, no. 5, pp. 4-7.
6. Ringden O., Myuller E. Primenenie mitogenov dlya funktsional`noy kharakteristiki subpopulyatsiy limfotsitov cheloveka. Limfotsity: vydelenie, fraktsionirovanie i kharakteristika / Pod red. Dzh. B. Natviga, P. Perlmanna, H. Vigzellya. [Mitogens using for the human lymphocyte subpopulations description. Lymphocytes: isolation, fractionating and characteristic. Ed. B. Natvig, P. Perlmann, X. Vigzell]. Moscow, Medicine, 1980, pp. 185-201.
7. Haitov R.M., Gushchin I.S., Pinegin B.V., Zebrev A.I. Rukovodstvo po eksperimental`nomu (doklinicheskomu) izucheniyu novykh farmakologicheskikh veshchestv [Manual of experimental (preclinic) investigation of present-day pharmacological substances]. Moscow, Medicine, 2000. 398 p.
8. Bannert N., Kurth R. Retroelements and the human genome: new perspectives on an old relation. Proc. Natl. Acad. Sci. U.S.A., 2004, vol. 5, no. 101, pp. 14572-14579.
9. Blank M. Cross-talk of the environment with the host genome and the immune system through endogenous retroviruses in systemic lupus erythematosus. Lupus, 2009, vol. 18, pp. 1136-1143.
10. Cho K., Lee Y.K., Greenhalgh D.G. Endogenous retroviruses in systemic response to stress signals. Shock, 2008, vol. 30, pp. 105-116.
11. Cianciolo G.J., Copeland T.D., Oroszlan S., Snyderman R. Inhibition of lymphocyte proliferation by a synthetic peptide homologous to retroviral envelope proteins. Science, 1985, vol. 230, pp. 453-455.
12. Compston A., Coles A. Multiple sclerosis. Lancet, 2008, vol. 372, pp. 1502-1517.
13. Gaidul K.V., Chernuchin I.V., Khaldoyanidi S.K., Svinarchuk F.P., Vlasov V.V., Kozlov V.A. Functional activity of T- , B-lymphocytes and macrophages under suppressed expression of endogenous retroviral gene env. Mol. Biol., 1995, vol. 29, pp. 359-362.
14. Gonsette R.E. Self-tolerance in multiple sclerosis. Acta Neurol. Belg., 2012, vol. 112, no. 2, pp. 133-140.
15. Haraguchi S., Good R.A., Day-Good N.K. A potent immunosuppressive retroviral peptide: cytokine patterns and signaling pathways. Immunol. Res., 2008, vol. 41, pp. 46-55.
16. Jern P., Coffin J.M. Effects of retroviruses on host genome function. Annu. Rev. Genet., 2008, vol. 42, pp. 709-732.
17. Koito A., Ikeda T. Intrinsinc immunity against retrotransposons by APOBEC cytidine deaminases. Frontiers in Microbiol., 2013, vol. 4, art. 28, pp. 1-9.
18. Natio T., Ogasawara H., Kaneko H., Hishikawa T., Sekigawa I., Hashimoto H., Maruyama N. Immune abnormalities induced by human endogenous retroviral peptides: with reference to the pathogenesis of systemic lupus erythematosus. J. Clin Immunol., 2003, vol. 23, pp. 371-376.
19. Nelson P.N., Carnegie P.R., Martin J., Davari Eitehadi H., Hooly P., Roden D., Rowland-Jones S., Warren P., Astley J., Murray P.G. Demystified… Human endogenous retroviruses. J. Clin. Pathol: Mol. Pathol., 2003, vol. 56, pp. 11-18.
20. Ogasawara H., Kaneko H., Hishikawa T., Sekigawa I., Takasaki Y., Hashimoto H., Hirosi S., Kaneko Y., Maruyama N. Molecular mimicry between human endogenous retrovirus clone 4-1 and HLA class I antigen with reference to the pathogenesis of systemic lupus erythematosus. Rheumatology, 1999, vol. 38, pp. 1163-1164.
21. De Olival G.S., Faria T.S., Nali L.H., de Olivieria A.C.P., Casseb L., Vidal J., Cavenaghi V., Tiberty C.P., Moraes L., Fink M.C.S., Sumita L.M., Perron H., Romano C.M. Genomic analysis of ERVWE2 locus in patients with multiple sclerosis: absence of genetic association but potential role of human endogenous retroviruses type W elements in molecular mimicry with myelin antigen. Front. in Microbiol., 2013, vol. 4, art. 172, pp. 1-7.
22. de Parseval N., Heidmann T. Human endogenous retroviruses: from infectious elements to human genes. Cytogenet. Genome Res., 2005, vol. 110, pp. 318-332.
23. Perron H., Lang A. The human endogenous retrovirus link between genes and environment in multiple sclerosis and in multifactorial diseases associating neuroinflammation. Clin. Rev. Allergy Immunol., 2010, vol. 39, pp. 51-61.
24. Piotrowski P.C., Duriaqin S., Jaqodzinski P.P. Expression of human endogenous retroviruses clone 4-1 may correlate with blood plasma concentration of anti - U1 RNP and anti-Sm nuclear antibodies. Clin. Rheumatol., 2005, vol. 24, no. 6, pp. 620-624.
25. Rakoff-Nahoum S., Kuebler P.J., Heymann J. J., Sheehy M.E., Oritz G.M., Ogg G.S., Barbour J.D., Lenz J., Steinfeld A.D., Nixon D.F. Detection of T lymphocytes specific for human endogenous retrovirus K (HERV-K) in patients with seminoma. AIDS Res. and Human Rretroviruses, 2006, vol. 1, pp. 52-56.
26. Sarasella M., Rolland A., Marventano T. Multiple sclerosis-associated retroviral agent (MSRV) –stimulated cytokine production in patients with relapsing-remitting multiple sclerosis. Mult. Scler., 2009, vol. 15, pp. 443-447.
27. Smagin A.A., Goldina I.A. Human endogenous retrovirus of class I λ 4-1 envelope gene expression in different types of blood mononuclear cells of multiple sclerosis patients. Materials 14th International Congress of Immunology Kobe, Japan, 2010. International Immunology, 2010, vol. 22, no. 1, pp. 38-30.
28. Trapp B.D., Nave K.A. Multiple sclerosis: an immune or neurodegenerative disorder? Annu. Rev. Neurosci., 2008, vol. 31, pp. 247-269.
29. Urnovitz H.B., Murphy W.H. Human endogenous Retroviruses: nature, occurrence, and clinical implications in human disease. Clin. Microbiol. Rev., 1996, vol. 9, no. 1, pp. 72-99.
30. Voisset C., Weiss R., Griffits J. Human RNA “Rumor” viruses: the search for novel human retroviruses in chronic disease. Microbiol. Mol. Biol. Rew., 2008, vol. 72, pp. 157-196.
31. Yi J.M., Kim H.S. Molecular phylogenetic analysis of the human endogenous retrovirus E (HERV-E) family in human tissues and human cancers. Genes Genet., 2007, vol. 82, no. 1, pp. 89-98.
Review
For citations:
Smagin A.A., Goldina I.A., Gaidul K.V., Lubarsky M.S. IN VITRO INDUCTION OF BLOOD MONONUCLEAR CELL PROLIFERATION BY ENDOGENOUS RETROVIRAL HERV-Eλ4-1 ENVELOPE PEPTIDE IN PATIENTS WITH MULTIPLE SCLEROSIS. Medical Immunology (Russia). 2014;16(3):247-256. (In Russ.) https://doi.org/10.15789/1563-0625-2014-3-247-256